2020 GeneSystems Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:2020 GeneSystems Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6452
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company. The company discovers, develops, and commercializes proteomics products and diagnostic tests for therapy selection, early disease detection, and biodefense applications. It provides tests in the areas of early detection of lung cancer, personalized medicine, and biological detection. 20/20 Gene’s blood test technology is used in the early detection of lung cancer and provides method for analysis of cell signaling in tissue and technologies to detect biological toxins. The company offers its products and services to drug companies, biodefense specialists and life scientists for protein analysis. 20/20 Gene is headquartered in Rockville, Maryland, the US.

2020 GeneSystems Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
20/20 GeneSystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
20/20 GeneSystems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
20/20 GeneSystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
20/20 GeneSystems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
20/20 GeneSystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
20/20 GeneSystems Inc, Medical Equipment, Deal Details 10
Venture Financing 10
20/20 GeneSystems Raises USD2 Million in Financing Round 10
20/20 GeneSystems Raises USD4.5 Million in Series A Financing 11
20/20 GeneSystems Raises USD2 Million in Financing 12
20/20 Gene Systems Raises USD1 Million in Financing Round 13
20/20 GeneSystems To Raise US$5 Million In Venture Financing 14
20/20 GeneSystems Secures USD0.15 Million in Venture Funding from Maryland Venture Fund 15
Equity Offering 16
20/20 GeneSystems Raises Funds through Private Placement 16
Acquisition 17
BHC Center of Financial & Investment Acquires Stake in 20/20 GeneSystems 17
20/20 GeneSystems Inc – Key Competitors 18
20/20 GeneSystems Inc – Key Employees 19
20/20 GeneSystems Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Product News 21
Aug 21, 2017: 20/20’s Lung Cancer Detection Technology Launches in China 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
20/20 GeneSystems Inc, Medical Equipment, Key Facts 2
20/20 GeneSystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
20/20 GeneSystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
20/20 GeneSystems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
20/20 GeneSystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
20/20 GeneSystems Inc, Deals By Market, 2012 to YTD 2018 8
20/20 GeneSystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
20/20 GeneSystems Raises USD2 Million in Financing Round 10
20/20 GeneSystems Raises USD4.5 Million in Series A Financing 11
20/20 GeneSystems Raises USD2 Million in Financing 12
20/20 Gene Systems Raises USD1 Million in Financing Round 13
20/20 GeneSystems To Raise US$5 Million In Venture Financing 14
20/20 GeneSystems Secures USD0.15 Million in Venture Funding from Maryland Venture Fund 15
20/20 GeneSystems Raises Funds through Private Placement 16
BHC Center of Financial & Investment Acquires Stake in 20/20 GeneSystems 17
20/20 GeneSystems Inc, Key Competitors 18
20/20 GeneSystems Inc, Key Employees 19
20/20 GeneSystems Inc, Subsidiaries 20

List of Figures
20/20 GeneSystems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
20/20 GeneSystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
20/20 GeneSystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
20/20 GeneSystems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
20/20 GeneSystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
20/20 GeneSystems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
20/20 GeneSystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
20/20 GeneSystems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[2020 GeneSystems Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 21st Century Oncology Inc:企業の戦略的SWOT分析
    21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • CK Infrastructure Holdings Ltd (1038):企業の財務・戦略的SWOT分析
    CK Infrastructure Holdings Ltd (1038) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Complete Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complete Genomics Inc (Complete Genomics), a subsidiary of BGI Genomics Co Ltd, is a human genome sequencing solutions provider. The company offers sequencing technology, process automation technology and data management solutions. It has sequenced whole human genomes using sequencing instru …
  • Duro Felguera SA (MDF):企業の財務・戦略的SWOT分析
    Duro Felguera SA (MDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • FalconStor Software Inc (FALC):企業の財務・戦略的SWOT分析
    Summary FalconStor Software Inc (FalconStor) is a technology company that offers data protection and storage virtualization solutions. The company offers freestor, continuous data protector, and network storage server. It offers freestor, which supports to manage data to deliver real-time informatio …
  • Censa Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Censa Pharmaceuticals Inc (Censa Pharmaceuticals) is a pharmaceutical company that develops and commercializes therapeutics for the treatment of rare central nervous system (CNS) disorders. The company provides product pipeline such as therapies for the treatment of extremely rare disorders …
  • Saxo Bank A/S:企業のM&A・事業提携・投資動向
    Saxo Bank A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Saxo Bank A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Laboratories Ojer Pharma SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Laboratories Ojer Pharma SL (Ojer Pharma) is a developer of pharmaceutical products in dermatology. The company's products categories include prescription medicine, over the counter OTC, medical devices and cosmetic products. It offers products such as previderm, dermatul nasal, dermatul lip …
  • Hofseth Biocare ASA:企業の戦略・SWOT・財務情報
    Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report Summary Hofseth Biocare ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • C.H. Robinson Worldwide Inc (CHRW):企業の財務・戦略的SWOT分析
    C.H. Robinson Worldwide Inc (CHRW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ambry Genetics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secur …
  • PT Bank China Construction Bank Indonesia Tbk:企業の戦略・SWOT・財務分析
    PT Bank China Construction Bank Indonesia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank China Construction Bank Indonesia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Delticom AG:企業の戦略・SWOT・財務情報
    Delticom AG - Strategy, SWOT and Corporate Finance Report Summary Delticom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Tetra Discovery Partners LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Tetra Discovery Partners LLC (Tetra Discovery) is a drug development company that researches and develops pharmaceutical drugs based on phosphodiesterase (PDE) sub-type inhibitors for neuroscience and non-neuroscience disorders. The company uses structure-guided drug design chemistry approac …
  • Shin Poong PharmCo Ltd (019170):製薬・医療:M&Aディール及び事業提携情報
    Summary Shin Poong PharmCo Ltd (Shin Poong) is a contract manufacturing company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. The company provides drugs such as psychoneurotic, anti-cancer, cardiovascular, antihistamine, antirheumatic and benign prostat …
  • Finning International Inc. (FTT):企業の財務・戦略的SWOT分析
    Finning International Inc. (FTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Labeyrie Fine Foods:企業の戦略・SWOT・財務分析
    Labeyrie Fine Foods - Strategy, SWOT and Corporate Finance Report Summary Labeyrie Fine Foods - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tufts Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • Superior Energy Services, Inc.:企業の戦略・SWOT・財務情報
    Superior Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Questerre Energy Corp (QEC):企業の財務・戦略的SWOT分析
    Summary Questerre Energy Corp (Questerre) is an independent oil and gas exploration and development company that acquires, explores, develops and produces unconventional oil and gas properties. The company’s unconventional properties include tight oil, shale oil and shale gas. It has base production …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆